| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Biomembranes et Messagers Cellulaires, and
Activation Cellulaire et Transduction des Signaux, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8619, Université Paris XI, Orsay, France
During the selection process in the thymus, most thymocytes are eliminated by apoptosis through signaling via TCR or glucocorticoids. The involvement of ceramide (Cer) and sphingosine (SP), important apoptotic mediators, remains poorly defined in glucocorticoid-induced apoptosis. We report that, in mouse thymocytes, apoptosis triggered by 10–6 M dexamethasone (DX) was preceded by a caspase-dependent Cer and SP generation, together with activation of acidic and neutral ceramidases. Apoptosis was drastically reduced by blocking either sphingolipid production (by acid sphingomyelinase inhibitor) or SP production (by ceramidase inhibitors), but not by inhibition of de novo Cer synthesis. Thus, SP generated through acid sphingomyelinase and ceramidase activity would contribute to the apoptotic effect of DX. Consistent with this hypothesis, SP addition or inhibition of SP kinase induced thymocyte apoptosis. DX induced a proteasome-dependent loss of mitochondrial membrane potential (
m) and caspase-8, -3, and -9 processing. Apoptosis was abolished by inhibition of m loss or caspase-8 or -3, but not caspase-9. m loss was independent of SP production and caspase-8, -3, and -9 activation. However, inhibition of SP production reduced caspase-8 and -3, but not caspase-9 processing. Proteasome inhibition impaired activation of the three caspases, whereas inhibition of m loss solely blocked caspase-9 activation. These data indicate that DX-induced apoptosis is mediated in part by SP, which contributes, together with proteasome activity, to caspase-8-3 processing independently of mitochondria, and in part by the proteasome/mitochondria pathway, although independently of caspase-9 activation.
This article has been cited by other articles:
|
|
 |
|
  S. Cuzzocrea, S. Bruscoli, E. Mazzon, C. Crisafulli, V. Donato, R. Di Paola, E. Velardi, E. Esposito, G. Nocentini, and C. Riccardi Peroxisome Proliferator-Activated Receptor-{alpha} Contributes to the Anti-Inflammatory Activity of Glucocorticoids Mol. Pharmacol., February 1, 2008; 73(2): 323 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Don, C. Martinez-Lamenca, W. R. Webb, R. L. Proia, E. Roberts, and H. Rosen Essential Requirement for Sphingosine Kinase 2 in a Sphingolipid Apoptosis Pathway Activated by FTY720 Analogues J. Biol. Chem., May 25, 2007; 282(21): 15833 - 15842. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bianchini, G. Nocentini, L. T. Krausz, K. Fettucciari, S. Coaccioli, S. Ronchetti, and C. Riccardi Modulation of Pro- and Antiapoptotic Molecules in Double-Positive (CD4+CD8+) Thymocytes following Dexamethasone Treatment J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 887 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wang, N. Muller, K. G. McPherson, and H. M. Reichardt Glucocorticoids Engage Different Signal Transduction Pathways to Induce Apoptosis in Thymocytes and Mature T Cells J. Immunol., February 1, 2006; 176(3): 1695 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Sionov, O. Cohen, S. Kfir, Y. Zilberman, and E. Yefenof Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis J. Exp. Med., January 23, 2006; 203(1): 189 - 201. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
